Alnylam Pharmaceuticals, Inc.
Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof

Abstract:

The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the xanthine dehydrogenase (XDH) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of an XDH gene and to methods of treating or preventing an XDH-associated disease in a subject.